Cue Health Inc. (HLTH)
NASDAQ: HLTH · IEX Real-Time Price · USD
0.0964
-0.0213 (-18.10%)
At close: May 17, 2024, 4:00 PM
0.104
+0.008 (7.78%)
After-hours: May 17, 2024, 7:59 PM EDT
Cue Health Stock Forecast
HLTH's stock price has decreased by -84.69% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Cue Health stock has a target of 0.50, which predicts an increase of 418.67% from the current stock price of 0.10.
Analyst Consensus: Hold
* Price targets were last updated on Nov 10, 2023.
Analyst Ratings
The average analyst rating for Cue Health stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2024 |
Goldman Sachs | Goldman Sachs | Hold Maintains $0.75 → $0.5 | Hold | Maintains | $0.75 → $0.5 | +418.67% | Nov 10, 2023 |
Goldman Sachs | Goldman Sachs | Hold Maintains $2.75 → $0.75 | Hold | Maintains | $2.75 → $0.75 | +678.01% | Jun 5, 2023 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $2.75 → $0.75 | Strong Buy → Hold | Downgrades | $2.75 → $0.75 | +678.01% | Jun 2, 2023 |
BTIG | BTIG | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +3,012.03% | May 15, 2023 |
Financial Forecast
Revenue This Year
58.12M
from 70.94M
Decreased by -18.06%
Revenue Next Year
111.99M
from 58.12M
Increased by 92.68%
EPS This Year
-1.12
from -2.44
EPS Next Year
-0.66
from -1.12
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 64.4M | 123.6M | 264.9M |
Avg | 58.1M | 112.0M | 211.5M |
Low | 53.5M | 98.0M | 159.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | -9.2% | 112.7% | 136.5% |
Avg | -18.1% | 92.7% | 88.8% |
Low | -24.6% | 68.6% | 42.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.88 | -0.41 | -0.11 |
Avg | -1.12 | -0.66 | -0.21 |
Low | -1.29 | -1.07 | -0.30 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.